Refinement of the Clinical Scenario Evaluation Framework for Assessment of Competing Development Strategies with an Application to Multiple Sclerosis

被引:0
|
作者
Tim Friede
Richard Nicholas
Nigel Stallard
Susan Todd
Nicholas Parsons
Elsa Valdés-Márquez
Jeremy Chataway
机构
[1] Warwick Medical School,
[2] The University of Warwick,undefined
[3] Imperial College Healthcare NHS Trust,undefined
[4] Applied Statistics,undefined
[5] University of Reading,undefined
[6] National Hospital for Neurology and Neurosurgery,undefined
[7] University Medical Center Göttingen,undefined
[8] Department of Medical Statistics,undefined
关键词
Clinical scenario evaluation; Drug development program; Clinical development; Adaptive seamless design; Multiple sclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
When competing strategies for development programs, clinical trial designs, or data analysis methods exist, the alternatives need to be evaluated in a systematic way to facilitate informed decision making. Here we describe a refinement of the recently proposed clinical scenario evaluation framework for the assessment of competing strategies. The refinement is achieved by subdividing key elements previously proposed into new categories, distinguishing between quantities that can be estimated from preexisting data and those that cannot and between aspects under the control of the decision maker from those that are determined by external constraints. The refined framework is illustrated by an application to a design project for an adaptive seamless design for a clinical trial in progressive multiple sclerosis.
引用
收藏
页码:713 / 718
页数:5
相关论文
共 50 条
  • [21] Development of an APP (ABOUTCOME) for evaluation in multiple sclerosis
    Di Giovanni, R.
    Solaro, C.
    Tacchino, A.
    Grange, E.
    Spirito, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 732 - 732
  • [22] Development of an app (ABOUTCOME) for evaluation in multiple sclerosis
    Di Giovanni, Rachele
    Grange, Erica
    Tacchino, Andrea
    Spirito, Marcella
    Solaro, Claudio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [23] Patient autonomy in multiple sclerosis - Possible goals and assessment strategies
    Heesen, C.
    Koepke, S.
    Solari, A.
    Geiger, F.
    Kasper, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 331 (1-2) : 2 - 9
  • [24] Application of filtering strategies to multiple sclerosis tremor: Analysis of results
    Avizzano, CA
    Brogni, A
    Bergamasco, M
    RO-MAN'99: 8TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTION, 1999, : 254 - 260
  • [25] Development of human biotransformation QSARs and application for PBT assessment refinement
    Papa, Ester
    Sangion, Alessandro
    Arnot, Jon A.
    Gramatica, Paola
    FOOD AND CHEMICAL TOXICOLOGY, 2018, 112 : 535 - 543
  • [26] Immunotherapy for Multiple Sclerosis: Basic insights for new clinical strategies
    Mouzaki, A
    Tselios, T
    Papathanassopoulos, P
    Matsoukas, I
    Chatzantoni, K
    CURRENT NEUROVASCULAR RESEARCH, 2004, 1 (04) : 325 - 340
  • [27] DESIGN STRATEGIES IN MULTIPLE-SCLEROSIS CLINICAL-TRIALS
    ELLISON, GW
    MYERS, LW
    LEAKE, BD
    MICKEY, MR
    KE, D
    SYNDULKO, K
    TOURTELLOTTE, WW
    ANNALS OF NEUROLOGY, 1994, 36 : S108 - S112
  • [28] Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design
    Kapoor, Raju
    CURRENT OPINION IN NEUROLOGY, 2006, 19 (03) : 255 - 259
  • [29] Comprehensive Clinical Assessment of Vestibular Function in Multiple Sclerosis
    Cochrane, Graham D.
    Christy, Jennifer B.
    Motl, Robert W.
    JOURNAL OF NEUROLOGIC PHYSICAL THERAPY, 2021, 45 (03): : 228 - 234
  • [30] Assessment of Clinical Symptoms of Periventricular Lesions in Multiple Sclerosis
    Javid, Muhammad Arshad
    Khan, Muhammad Afzal
    Warrich, Mustansar Mahmood
    RAWAL MEDICAL JOURNAL, 2012, 37 (04): : 395 - 398